Search

everythinglearnresearchcommunity

for

Search:↓

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Keratosis Pilaris Atrophicans causes skin scarring and might be treated with a new synthetic retinoid.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

Lack of KSR1 stops certain skin tumors in mice.

Sorafenib can cause rare skin reactions, but treatment can continue with additional care.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

Laser treatments are the most effective for porokeratotic adnexal ostial nevus.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

PRSS35 enzyme may help start skin tumors and could be a target for cancer treatment.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

A vitamin D receptor mutation causes rickets and affects immune responses.

Mutations in the ACTB gene cause Becker’s nevi and may lead to muscle issues in Becker’s nevus syndrome.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

KRT14 gene variants cause dermatopathia pigmentosa reticularis, affecting nails, teeth, and hair.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Four antibodies were developed to help study hair follicle cell differentiation.

New mutations in MBTPS2 reduce its function and cause IFAP syndrome with unusual symptoms.

Scientists found a new protein, AMY117, common in Alzheimer's patients, which could be important for treatment and diagnosis.

A new gene mutation causes vitamin D-resistant rickets and hair loss in two siblings.

Skin tumor regression is helped by retinoic acid signaling blocking Wnt signaling.

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.

The study aims to find the best treatment for central serous chorioretinopathy by comparing various options.

A specific gene mutation causes vitamin D-resistant rickets and hair loss.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.